Remote Ischemic Conditioning for Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage (RIC-CAAH)
Safety and Efficacy of Remote Ischemic Conditioning in Patients With Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage:A Multicenter, Randomized, Controlled Study
Sponsor: Bejing Fengtai You'anmen Hospital
Listed as NCT04757597, this NA trial focuses on Cerebral Amyloid Angiopathy and Intracerebral Hemorrhage Lobar and remains ongoing. Sponsored by Bejing Fengtai You'anmen Hospital, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jul 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Sep 2021 — Jul 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
First recorded
Feb 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bejing Fengtai You'anmen Hospital
- Capital Medical University
- Wangjing Hospital, China Academy of Chinese Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .